Caisson Biotech, LLC
https://caissonbiotech.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Caisson Biotech, LLC
Peptineo LLC
Delivering the right drugs to the right place at the right time has always been a challenge for the biopharmaceutical industry. Peptineo LLC aims to meet that challenge by developing and commercializing nanoscale technologies and materials for drug delivery and drug discovery. Its aim is to improve the delivery of drugs in development, extend the life cycle of marketed drugs, and repurpose existing or failed compounds.
Novo Nordisk Looks Ahead After Tresiba Setback, Bets Against Biosimilars
The Danish pharma is focused on the latest formulation technology for insulin and GLP-1 and combinations thereof to sustain its diabetes market leader position. It’s not particularly worried about biosimilars, despite two of its top sellers coming off-patent in the next few years.
Deals Shaping The Medical Industry, June 2012
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Company Information
- Industry
- Biotechnology
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice